Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) FCF Margin (2020 - 2022)

Historic FCF Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 2597344.18%.

  • Immuneering's FCF Margin fell 25924641800.0% to 2597344.18% in Q4 2022 from the same period last year, while for Sep 2023 it was 10809489.45%, marking a year-over-year decrease of 108011355900.0%. This contributed to the annual value of 14148.44% for FY2022, which is 126622700.0% down from last year.
  • Immuneering's FCF Margin amounted to 2597344.18% in Q4 2022, which was down 25924641800.0% from 28701.08% recorded in Q3 2022.
  • In the past 5 years, Immuneering's FCF Margin ranged from a high of 511.54% in Q3 2020 and a low of 2597344.18% during Q4 2022
  • For the 3-year period, Immuneering's FCF Margin averaged around 265287.05%, with its median value being 3378.13% (2021).
  • As far as peak fluctuations go, Immuneering's FCF Margin crashed by -13647100bps in 2021, and later crashed by 2000000000bps in 2022.
  • Over the past 3 years, Immuneering's FCF Margin (Quarter) stood at 825.64% in 2020, then crashed by -491bps to 4880.0% in 2021, then crashed by -53124bps to 2597344.18% in 2022.
  • Its FCF Margin was 2597344.18% in Q4 2022, compared to 28701.08% in Q3 2022 and 10182.56% in Q2 2022.